Navigation Links
Concerned Stockholders Launch Save Vermillion! Website: www.savevrml.com
Date:2/1/2013

PHILADELPHIA, Feb. 1, 2013 /PRNewswire/ -- George Bessenyei , Gregory V. Novak , and Robert S. Goggin (the "Group") today launched their website, www.savevrml.com, to provide all stockholders access to relevant information concerning Vermillion Inc.'s (the "Company" or "Vermillion") contested 2012 Annual Stockholder meeting (the "2012 Annual Meeting").

The road to forcing Vermillion's Board to schedule the annual meeting has been anything but easy, short, or smooth.  Almost a year ago, on February 15, 2012, the Group announced its intention to nominate Robert S. Goggin as Director Nominee for the 2012 Annual Meeting. After a series of dodge ball tactics by the Board and Gail Page , more recently, on January 9, 2013, Bessenyei filed a complaint in the Delaware Chancery Court ("Court"), asking the Court to order the Company to call and hold an annual meeting of stockholders at the earliest practicable date. This maneuver was necessary, given what the Group believes was management's stonewalling, to finally force the Company to abide by its own Bylaws, Delaware law and to avoid a NASDAQ delisting process, and call the 2012 meeting.  After the complaint was filed, the Company finally set the meeting date for March 21st, 2013.

In order to provide more information to stockholders, the Group today launched its website. Major topics include: 

  • Robert S. Goggin 's Five Point Turnaround Plan for Vermillion
  • Comprehensive analysis of OVA1 and its market potential
  • Biography of Group members
  • Timeline of events leading to the 2012 Annual Meeting
  • Compensation counter tracking the benefits provided to Vermillion Directors over the past several years, currently standing at a staggering $13,176,632
  • The Reverse Midas Touch: Chairman James S. Burns ' track record at public companies*

Visit our webpage today!

The Group's proxy statement (the "Group Proxy Statement"), filed on January 29, 2013, is available free of charge at www.sec.gov.  The Group Proxy Statement will first be sent or given to stockholders on or about February 6, 2013.  Stockholders are advised to read the Group Proxy Statement and the other documents relating to the Group's solicitation of proxies by members of the Group from stockholders of the Company for use at its 2012 Annual Meeting because they contain important information.

*( James S. Burns serves as Chairman of the Board at Vermillion; he is also a Director at Symmetry Medical, Inc. and Chief Executive Officer at AssureRx Health, Inc.)

Stockholders please contact Okapi Partners LLC
Patrick McHugh / Geoff Sorbello
(212) 297-0720

Concerned Vermillion Stockholders
T: 561-444-8180
Email: concerned_vrml@googlegroups.com


'/>"/>
SOURCE Concerned Vermillion Stockholders
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Mangrove Partners Sends Letter to Stockholders of Nabi Biopharmaceuticals
2. Bacterin Receives Letter From NYSE MKT LLC Regarding Timely Notice of Record Date for 2012 Annual Meeting of Stockholders
3. Generex Announces Date of Annual Stockholders Meeting
4. Amarantus BioScience Launches New Website
5. Touch Medical Media Splits From Touch Briefings, Launches a Series of Cutting Edge, Free to Access, Educational Resources and Signs an Updated Media Partnership With ECCO, The European CanCer Organisation Representing 60,000 Oncology Professionals
6. Find New Cancer Treatments at cureLauncher
7. New York Microscope Launches New Website http://www.NYscopes.com
8. MDA Launches Clinical Network to Speed Myotonic Dystrophy Research
9. DuPont Pioneer Launches Next Generation T Series Soybeans
10. MedZilla.com Launches New Site Design for 2013, Slick New Interface Impresses
11. Nerium Announcing Launch of New Blog Sites
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... and ROCKVILLE, Md. , March ... of Maxwell Biotech Venture Fund (MBVF), today announced positive ... added to the standard drug therapy regimen in patients ... small molecule drug discovered by scientists at Sequella, Inc. ... Institutes of Health. A total of ...
(Date:3/24/2017)... 2017 Agenus Inc. (NASDAQ: AGEN), an immuno-oncology ... cancer vaccines, today announced participation at the following conferences: ... Blair and Maidstone Life Sciences conference "Cancer Immunotherapy Conference" ... New York, NY . Agenus will participate ... 9:40 am: Robert B. Stein , M.D., Ph.D., ...
(Date:3/23/2017)... 23, 2017  SeraCare Life Sciences, Inc., a ... vitro diagnostics manufacturers and clinical laboratories, is ... multiplexed Inherited Cancer reference material ... next-generation sequencing (NGS). The Seraseqâ„¢ Inherited Cancer DNA ... from industry experts to validate the ability ...
(Date:3/23/2017)... YORK , March 23, 2017 ... ... of death, putting significant strain on health care systems, in ... cancer diagnoses rises, so too does the development of innovative ... minimum side effects. Among the many types of cancer treatments, ...
Breaking Biology Technology:
(Date:2/28/2017)... Germany , February 28, 2017 News ... ... Amsterdam from 14 to 16 March, Materna ... destination, and show how seamless travel is a real benefit for ... has added biometrics to their passenger touch point solutions to take ...
(Date:2/22/2017)... 2017 With the biometrics market to ... four technologies that innovative and agile startups must ... in the changing competitive landscape: multifactor authentication (MFA), ... "Companies can no longer afford to ... Dimitrios Pavlakis , Industry Analyst at ABI ...
(Date:2/13/2017)... , Feb. 13, 2017  RSA Conference -- ... platform that is designed to enhance fraud detection ... release in the RSA Fraud & Risk Intelligence ... organizations to leverage additional insights from internal and ... to better protect their customers from targeted cybercrime ...
Breaking Biology News(10 mins):